$LUNR
Intuitive Machines, Inc. Stock $lunr

$lunr Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024857 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$18.24M	$0.00	$0.00
YoY Change
Cost Of Revenue	$23.13M		$75.51M
YoY Change	17.17%		-24.72%
Gross Profit	-$4.890M		$10.43M
YoY Change	285.04%		-137.57%
Gross Profit Margin	-26.82%
Selling, General & Admin	$8.780M		$14.87M
YoY Change	194.63%		60.06%
% of Gross Profit			142.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$296.0K	$820.0K	$1.070M
YoY Change	19.35%		27.38%
% of Gross Profit			10.26%
Operating Expenses	$9.070M	$2.087M	$5.024M
YoY Change	2507.3%	364.15%	922.55%
Operating Profit	-$13.96M		-$5.024M
YoY Change	210.29%		-82.22%
Interest Expense	-$279.0K	$2.847M	$4.834M
YoY Change	-1117.88%	50738.93%	83241.21%
% of Operating Profit
Other Income/Expense, Net	-$6.269M	$0.00	$0.00
YoY Change	-4042.77%	-100.0%	-100.0%
Pretax Income	-$20.23M	$759.6K	-$190.4K
YoY Change	6213.42%	-377.14%	-39.65%
Income Tax	$3.200M		-$20.00K
% Of Pretax Income
Net Earnings	-$9.360M	$759.6K	-$190.4K
YoY Change	2820.85%	-377.14%	-39.65%
Net Earnings / Revenue	-51.33%
Basic Earnings Per Share	-$0.64
Diluted Earnings Per Share	-$0.64	$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	84.17M shares
Diluted Shares Outstanding	15.22M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.80M	$14.93K	$14.93K
YoY Change	28474.92%	-95.85%	-95.85%
Cash & Equivalents	$46.80M	$14.93K	$25.76M
Short-Term Investments
Other Short-Term Assets	$4.800M	$335.9K	$335.9K
YoY Change	838.64%	-29.37%	-29.37%
Inventory
Prepaid Expenses		$335.9K
Receivables	$2.308M	$1.302M	$8.280M
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$65.60M	$350.8K	$350.8K
YoY Change	9616.52%	-57.99%	-57.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.45M	$21.18M	$26.01M
YoY Change			238.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$334.6M	$334.6M
YoY Change		1.47%	1.47%
Other Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Total Long-Term Assets	$34.10M	$334.6M	$334.6M
YoY Change	-89.67%	1.37%	1.37%
TOTAL ASSETS
Total Short-Term Assets	$65.60M	$350.8K	$350.8K
Total Long-Term Assets	$34.10M	$334.6M	$334.6M
Total Assets	$99.71M	$334.9M	$334.9M
YoY Change	-69.85%	1.22%	1.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.90M		$6.520M
YoY Change			126.39%
Accrued Expenses	$800.0K	$3.696M	$3.696M
YoY Change	169.71%	1592.08%	1592.08%
Deferred Revenue	$50.07M	$56.66M
YoY Change
Short-Term Debt	$0.00	$112.5K	$112.5K
YoY Change		10817.48%	10817.48%
Long-Term Debt Due	$16.10M	$16.10M	$16.10M
YoY Change			32.95%
Total Short-Term Liabilities	$108.1M	$4.433M	$4.433M
YoY Change	36329.1%	1920.16%	1920.19%
LONG-TERM LIABILITIES
Long-Term Debt	$3.868M	$3.863M	$0.00
YoY Change
Other Long-Term Liabilities	$4.000K	$0.00	$0.00
YoY Change	-99.97%	-100.0%	-100.0%
Total Long-Term Liabilities	$3.872M	$3.863M	$0.00
YoY Change	-66.45%	-66.53%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$108.1M	$4.433M	$4.433M
Total Long-Term Liabilities	$3.872M	$3.863M	$0.00
Total Liabilities	$220.9M	$4.433M	$4.433M
YoY Change	1765.63%	-62.3%	-62.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$870.5M	-$505.9K
YoY Change		60.35%
Common Stock		$139.00
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$883.3M	$9.787M	$330.5M
YoY Change
Total Liabilities & Shareholders Equity	$99.71M	$334.9M	$334.9M
YoY Change	-69.85%	1.22%	1.22%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$9.360M	$759.6K	-$190.4K
YoY Change	2820.85%	-377.14%	-39.65%
Depreciation, Depletion And Amortization	$296.0K	$820.0K	$1.070M
YoY Change	19.35%		27.38%
Cash From Operating Activities	-$18.67M	-$504.5K	-$969.7K
YoY Change	9431.74%	82.02%	-19.5%
INVESTING ACTIVITIES
Capital Expenditures	$8.565M	$16.03M	$16.41M
YoY Change	2171.88%		416.04%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$8.565M	$0.00
YoY Change	2171.88%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$48.27M	500.0K	$625.0K
YoY Change	1053.08%	-98.32%	-99.81%
NET CHANGE
Cash From Operating Activities	-$18.67M	-504.5K	-$969.7K
Cash From Investing Activities	-$8.565M	0.000
Cash From Financing Activities	$48.27M	500.0K	$625.0K
Net Change In Cash	$21.04M	-4.510K	-$344.7K
YoY Change	-10842.48%	-98.37%	-195.85%
FREE CASH FLOW
Cash From Operating Activities	-$18.67M	-$504.5K	-$969.7K
Capital Expenditures	$8.565M	$16.03M	$16.41M
Free Cash Flow	-$27.23M	-$16.53M	-$17.38M
YoY Change	4653.77%		296.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40823
CY2022	dei	Entity Registrant Name EntityRegistrantName	Intuitive Machines, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-5056189
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3700 Bay Area Blvd
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77058
CY2022	dei	City Area Code CityAreaCode	(281)
CY2022	dei	Local Phone Number LocalPhoneNumber	520-3703
CY2022	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	LUNR
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	319527750	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84172557	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14932	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	359610	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	335888	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	475532	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	350820	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	835142	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	326032	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	334589588	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	329755798	usd
CY2022Q4	us-gaap	Assets Assets	334940408	usd
CY2021Q4	us-gaap	Assets Assets	330916972	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3695849	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	218421	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	112448	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1032	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	625000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4433297	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	219453	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	11541250	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4433297	usd
CY2021Q4	us-gaap	Liabilities Liabilities	11760703	usd
CY2022Q4	ipax	Ordinary Share Subject To Possible Redemption OrdinaryShareSubjectToPossibleRedemption	31588011	shares
CY2021Q4	ipax	Ordinary Share Subject To Possible Redemption OrdinaryShareSubjectToPossibleRedemption	31588011	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	320719698	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	315880110	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	139	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	139	usd
CY2022Q4	ipax	Common Stock Value1 CommonStockValue1	825	usd
CY2021Q4	ipax	Common Stock Value1 CommonStockValue1	825	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10292368	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3590706	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-505919	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315511	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9787413	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3276159	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	334940408	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	330916972	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5024198	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	491341	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5024198	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-491341	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	193471	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	23439	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4833790	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5798	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4833790	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	175830	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-190408	usd
	us-gaap	Net Income Loss NetIncomeLoss	-315511	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	ipax	Sale Of Private Placement Warrants Net Of Offering Costs SaleOfPrivatePlacementWarrantsNetOfOfferingCosts	6845000	shares
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6831701	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	9680125	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1386989	shares
	ipax	Sale Of Units Not Subject To Redemption Net Of Underwriter Discount And Offering Costs SaleOfUnitsNotSubjectToRedemptionNetOfUnderwriterDiscountAndOfferingCosts	12756972	usd
	ipax	Allocated Proceeds To Public Warrants Net Of Underwriter Discount And Offering Costs AllocatedProceedsToPublicWarrantsNetOfUnderwriterDiscountAndOfferingCosts	11025229	usd
	ipax	Forfeiture Of Founder Shares ForfeitureOfFounderShares	381250	shares
	ipax	Fair Value Of Overallotment At Issuance FairValueOfOverallotmentAtIssuance	87830	usd
	ipax	Remeasurement Of Class A Ordinary Shares Subject To Redemption RemeasurementOfClassAOrdinarySharesSubjectToRedemption	-36815188	usd
	us-gaap	Net Income Loss NetIncomeLoss	-315511	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3276159	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-4839588	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	11541250	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-190408	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9787413	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-190408	usd
	us-gaap	Net Income Loss NetIncomeLoss	-315511	usd
	ipax	Formation Cost Paid By The Sponsor In Exchange For Issuance Of Class B Ordinary Shares FormationCostPaidByTheSponsorInExchangeForIssuanceOfClassBOrdinaryShares	11388	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	8500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-193471	usd
	us-gaap	Gain Loss On Sale Of Project GainLossOnSaleOfProject	-23439	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	4833790	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	5798	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-465676	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	475532	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	326032	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	111416	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1032	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3477428	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	67421	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-969678	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1204564	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	329750000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-329750000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6845000	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	325155000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	188805	usd
CY2022	ipax	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan	625000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	497021	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	625000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	331314174	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-344678	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	359610	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	359610	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14932	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	359610	usd
	us-gaap	Stock Issued1 StockIssued1	13612	usd
	ipax	Deferred Offering Cost Paid By Related Party DeferredOfferingCostPaidByRelatedParty	180305	usd
	ipax	Capital Contribution For Excess Fair Value Of Class B Shares Sold By The Sponsor To Anchor Investor CapitalContributionForExcessFairValueOfClassBSharesSoldByTheSponsorToAnchorInvestor	9680125	usd
	ipax	Deferred Underwriting Commissions Payable Charged To Additional Paid In Capital DeferredUnderwritingCommissionsPayableChargedToAdditionalPaidInCapital	11541250	usd
CY2022	ipax	Accretion Of Class A Ordinary Shares Subject To Possible Redemptionin Shares AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares	4839588	usd
	ipax	Accretion Of Class A Ordinary Shares Subject To Possible Redemptionin Shares AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares	36815188	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	11541250	usd
	ipax	Accrued Offering Costs AccruedOfferingCosts	151000	usd
CY2021Q3	ipax	Number Of Shares NumberOfShares	1	shares
CY2021Q3	ipax	Temporary Equity Per Share TemporaryEquityPerShare	11.5
CY2022Q4	ipax	Number Of Shares NumberOfShares	1	shares
CY2022	ipax	Purchased Units Percentage PurchasedUnitsPercentage	1	pure
CY2022	ipax	Aggregate Founder Shares AggregateFounderShares	1625000	shares
CY2022	ipax	Founder Shares Price FounderSharesPrice	9680000	usd
CY2022	ipax	Founder Shares Price Per Share FounderSharesPricePerShare	5.96
CY2022Q4	ipax	Transaction Costs Amounted TransactionCostsAmounted	26658313	usd
CY2022Q4	ipax	Underwriting Commissions UnderwritingCommissions	4595000	usd
CY2022Q4	ipax	Deferred Underwriting Commissions DeferredUnderwritingCommissions	11541250	usd
CY2022	ipax	Excess Fair Value Of Founder Shares ExcessFairValueOfFounderShares	9680125	usd
CY2022Q4	ipax	Other Offering Costs OtherOfferingCosts	841938	usd
CY2022	ipax	Allocation For Overallotment Option AllocationForOverallotmentOption	23439	usd
CY2022Q4	ipax	Allocated Temporary Equity AllocatedTemporaryEquity	24538134	usd
CY2022Q4	ipax	Ordinary Shares Not Subject To Redemption OrdinarySharesNotSubjectToRedemption	2096740	usd
CY2021Q4	ipax	Sale Of Units Price SaleOfUnitsPrice	29750000	usd
CY2021Q4	ipax	Sale Of Units Price Per Share SaleOfUnitsPricePerShare	10
CY2022	us-gaap	Common Stock Voting Rights CommonStockVotingRights	three
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.10	pure
CY2022Q4	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	700000000	usd
CY2022	ipax	Consideration And Structure Description ConsiderationAndStructureDescription	In particular, the business combination consideration received by the Intuitive Machines Members comprised of an aggregate of (a) (i) 68,125,987 Intuitive Machines OpCo Common Units, (ii) 1,874,013 Intuitive Machines OpCo Options and (iii) 10,000,000 Earn Out Units and (b) (i) 278 shares of New Intuitive Machines Class B Common Stock (excluding 1,874,013 shares of New Intuitive Machines Class B Common Stock reserved for issuance upon exercise of Intuitive Machines OpCo Options) and (ii) 68,125,709 shares of New Intuitive Machines Class C Common Stock (excluding 10,000,000 shares of New Intuitive Machines Class C Common Stock reserved for issuance upon vesting of the Earn Out Units).The 10,000,000 Earn Out Units received by the applicable Intuitive Machines Members are subject to vesting and will be earned, released and delivered upon satisfaction of the following milestones: (i) 2,500,000 Earn Out Units will vest if, during the Earn Out Period (as defined below), Intuitive Machines is awarded the OMES III Contract by NASA (“Triggering Event I”), (ii) 5,000,000 Earn Out Units will vest if, within the Earn Out Period, Triggering Event I occurs and the volume weighted average closing sale price of New Intuitive Machines Class A Common Stock equals or exceeds $15.00 per share (“Triggering Event II-A”), (iii) 7,500,000 Earn Out Units will vest if, within the Earn Out Period, Triggering Event I has not occurred and the volume weighted average closing sale price of New Intuitive Machines Class A Common Stock equals or exceeds $15.00 per share (“Triggering Event II-B”), and (iv) 2,500,000 Earn Out Units will vest if, within the Earn Out Period, Triggering Event III occurs the volume weighted average closing sale price of New Intuitive Machines Class A Common Stock equals or exceeds $17.50 per share (“Triggering Event III”), provided, that Triggering Event II-A and Triggering Event II-B may not both be achieved. “Earn Out Period” means (i) with respect to Triggering Event I, the time period beginning on September 16, 2022 and ending at 11:59 pm ET on December 31, 2023, and (ii) with respect to Triggering Event II-A, Triggering Event II-B and Triggering Event III, the time period beginning on the date that is 150 days following the date of Closing and ending on the date that is the five (5) year anniversary of the date of Closing. If a Change of Control (as defined in the Business Combination Agreement) occurs during the Earn Out Period that results in the holders of New Intuitive Machines Class A Common Stock receiving a per share price greater than or equal to $15.00 or $17.50, respectively, then immediately prior to the consummation of such Change of Control, to the extent not previously triggered, then Triggering Event II-A or Triggering Event II-B will be deemed to have occurred, as applicable, and the applicable Earn Out Units shall vest.
CY2022	ipax	Public Shares Held In Trust Account Description PublicSharesHeldInTrustAccountDescription	the expiration of the applicable lock-up period, holders of certain Intuitive Machines OpCo Common Units will be permitted to exchange such Intuitive Machines OpCo Common Units (along with the cancellation of the paired share of New Intuitive Machines Class B Common Stock or share of New Intuitive Machines Class C Common Stock) for shares of New Intuitive Machines Class A Common Stock on a one-for-one basis pursuant to the second amended and restated limited liability company agreement of Intuitive Machines OpCo (the “Second A&R Operating Agreement”) (subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications) or, at the election of New Intuitive Machines (determined by a majority of the directors of New Intuitive Machines who are disinterested with respect to such determination), cash from a substantially concurrent public offering or private sale in an amount equal to the net amount, on a per share basis, of cash received as a result of such public offering or private sale.
CY2022Q3	us-gaap	Preferred Stock Capital Shares Reserved For Future Issuance PreferredStockCapitalSharesReservedForFutureIssuance	26000	shares
CY2022Q3	ipax	Cumulative Convertible Stock Percentage CumulativeConvertibleStockPercentage	0.10	pure
CY2022Q3	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	541667	usd
CY2022Q3	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	15
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.85	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.85	pure
CY2022	ipax	Tra Holdings Rate Tax Percentage TRAHoldingsRateTaxPercentage	0.05	pure
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	169200000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	147200000	usd
CY2022	ipax	Purchase Price PurchasePrice	10
CY2022Q4	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	99700000	usd
CY2022Q3	ipax	New Issue NewIssue	50000000	usd
CY2022Q3	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	100000	shares
CY2022	us-gaap	Net Shares Reclassified To Mandatorily Redeemable Capital Stock Shares NetSharesReclassifiedToMandatorilyRedeemableCapitalStockShares	2900000	shares
CY2022Q4	ipax	Operating Bank Account OperatingBankAccount	14932	usd
CY2022Q4	ipax	Working Capital WorkingCapital	4082477	usd
CY2021Q3	ipax	Aggregate Loans AggregateLoans	250000	usd
CY2022Q1	ipax	Working Capital WorkingCapital	500000	usd
CY2022	ipax	Warrant Description WarrantDescription	The Sponsor will have the option, at any time on or prior to the Maturity Date, to convert up to $1,000,000 outstanding under the Working Capital Note into warrants to purchase Class A ordinary shares at a conversion price of $1.00 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants. As of December 31, 2022, there was $625,000 outstanding under the Working Capital Note.
CY2022	ipax	Gross Proceeds GrossProceeds	34000000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of credit risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Derivative Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Company has analyzed the Public Warrants and Private Placement Warrants and determined they meet all of the requirements for equity classification under ASC 815 (see Notes 3 and 4).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	ipax	Transaction Costs Amounted TransactionCostsAmounted	26658313	usd
CY2022Q4	ipax	Underwriting Commissions UnderwritingCommissions	4595000	usd
CY2022Q4	ipax	Deferred Underwriting Commissions DeferredUnderwritingCommissions	11541250	usd
CY2022	ipax	Excess Fair Value Of Founder Shares ExcessFairValueOfFounderShares	9680125	usd
CY2022Q4	ipax	Other Offering Costs OtherOfferingCosts	841938	usd
CY2022	ipax	Allocation For Overallotment Option AllocationForOverallotmentOption	23439	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	329750000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	13869890	usd
	ipax	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-11995753	usd
	ipax	Overallotment Liability OverallotmentLiability	281301	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-24538134	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	36815188	usd
CY2021Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	315880110	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	4839588	usd
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	320719698	usd
CY2021Q3	ipax	Initial Business Combination Expire InitialBusinessCombinationExpire	P5Y
CY2021Q4	ipax	Aggregate Gross Proceeds AggregateGrossProceeds	29750000	usd
CY2022Q4	us-gaap	Common Stocks Including Additional Paid In Capital Net Of Discount CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount	595000	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.35
CY2022	ipax	Aggregate Amount AggregateAmount	11541250	usd
CY2022Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	11541250	usd
CY2022	ipax	Fees Amount FeesAmount	0	usd
	ipax	Fees Amount FeesAmount	11541250	usd
	ipax	Public Warrants Outstanding Shares PublicWarrantsOutstandingShares	16487500	shares
CY2022	ipax	Public Warrants Outstanding Shares PublicWarrantsOutstandingShares	16487500	shares
CY2022	ipax	Private Warrants Outstanding Shares PrivateWarrantsOutstandingShares	6845000	shares
	ipax	Private Warrants Outstanding Shares PrivateWarrantsOutstandingShares	6845000	shares
CY2022	ipax	Initial Business Combination Expire InitialBusinessCombinationExpire	P5Y
CY2022	ipax	Redemption Of Warrants Description RedemptionOfWarrantsDescription	Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before it sends the notice of redemption to the warrant holders.
CY2022	ipax	Aggregate Purchase Price Amount AggregatePurchasePriceAmount	6250000	usd
CY2021Q4	ipax	Gross Proceeds GrossProceeds	595000	usd
CY2021Q4	ipax	Sponsor Forfeited SponsorForfeited	381250	shares
CY2022	ipax	Fair Value Of Founder Shares FairValueOfFounderShares	9680000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.96
CY2021Q3	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	188805	usd
CY2021Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	250000	usd
CY2022	ipax	Description Of Working Capital Note DescriptionOfWorkingCapitalNote	Up to an aggregate of $1,500,000 outstanding under the Working Capital Loans may be convertible into warrants to purchase Class A ordinary shares at a conversion price of $1.00 per warrant at the option of the lender, with each warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants. If the Company completes an Initial Business Combination, the Company would repay the Working Capital Loans, unless they are converted into warrants. In the event that an Initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans.
CY2022	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	The Sponsor will have the option, at any time on or prior to the Maturity Date, to convert up to $1,000,000 outstanding under the Working Capital Note into warrants to purchase Class A ordinary shares at a conversion price of $1.00 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants.
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	625000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	0	usd
CY2021Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	15000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	180000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	48000	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	150000	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	40000	usd
CY2022	ipax	Fee Amount FeeAmount	41667	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	189980	usd
CY2021Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	63678	usd
CY2022	ipax	Registration Rights Description RegistrationRightsDescription	Pursuant to the registration rights agreement and assuming $1,500,000 of Working Capital Loans are converted into additional warrants, the Company will be obligated to register up to 21,588,750 Class A ordinary shares and 8,345,000 warrants. The number of Class A ordinary shares includes (i) 8,243,750 Class A ordinary shares to be issued upon conversion of the Founder Shares, (ii) 5,000,000 Forward Purchase Shares, (iii) 6,845,000 Class A ordinary shares underlying the Private Placement Warrants and (iv) 1,500,000 Class A ordinary shares underlying the warrants issuable upon conversion of Working Capital Loans. The number of warrants includes 6,845,000 Private Placement Warrants and 1,500,000 additional warrants issuable upon the conversion of Working Capital Loans.
CY2021Q3	ipax	Underwriting Discount UnderwritingDiscount	0.02	pure
CY2021Q3	ipax	Underwriting Discountvalue UnderwritingDiscountvalue	4000000	usd
CY2021Q3	ipax	Aggregate Units AggregateUnits	10000000	shares
CY2022	ipax	Deferred Underwriting Discount DeferredUnderwritingDiscount	0.035	pure
CY2022Q4	ipax	Deferred Underwriting Commission DeferredUnderwritingCommission	11541250	usd
CY2022Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	11541250	usd
CY2022	ipax	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	0	usd
	ipax	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	11541250	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	ipax	Ordinary Share Subject To Possible Redemption OrdinaryShareSubjectToPossibleRedemption	31588011	shares
CY2021Q4	ipax	Purchase An Additional Units PurchaseAnAdditionalUnits	2975000	shares
CY2021Q4	ipax	Share Per Value SharePerValue	10	shares
CY2021Q4	us-gaap	Share Price SharePrice	10
CY2021Q3	us-gaap	Share Price SharePrice	10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	10
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.045	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.044	pure
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y10D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y1M13D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	ipax	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0008	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0006	pure
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	281301	usd
	ipax	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	-148449	usd
	ipax	Fair Value Of Expired Overallotment Option FairValueOfExpiredOverallotmentOption	-45022	usd
	ipax	Elimination Of Overallotment Liability EliminationOfOverallotmentLiability	-87830	usd
CY2022	us-gaap	Subsequent Event Description SubsequentEventDescription	the Company’s extraordinary general meeting held on February 8, 2023, 27,481,818 holders of IPAX Class A Ordinary Shares exercised their right to redeem those shares for cash at a price of approximately $10.1843 per share, for an aggregate of $279,884,314 (the “Redemptions”). As previously announced, on February 9, 2023, IPAX and Intuitive Machines OpCo entered into separate agreements (each, a “Forward Purchase Agreement”, and together, the “Forward Purchase Agreements”) with each of Polar Multi-Strategy Master Fund (“Polar”) and The HGC Fund LP (“HGC” and, each of Polar and HGC, individually, a “Seller” and, together, the “Sellers”) for over-the-counter Equity Prepaid Forward Transactions, pursuant to which each Seller agreed to hold, and waive any redemption rights with respect to, a maximum of 1,250,000 Cayman Class A Shares in connection with the closing of the Business Combination. Each Seller, acting separately and solely for its own account, was entitled to (i) reverse its previous election to redeem its Cayman Class A Shares in connection with the Business Combination or (ii) purchase Cayman Class A Shares through a broker in the open market from holders of Cayman Class A Shares (other than IPAX), including from holders who had previously elected to redeem their Cayman Class A Shares in connection with the Business Combination, such that, in the aggregate, such Seller owned up to 1,250,000 Cayman Class A Shares as of the Closing Date.
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	ipax	Formation Cost Paid By The Sponsor In Exchange For Issuance Of Class B Ordinary Shares FormationCostPaidByTheSponsorInExchangeForIssuanceOfClassBOrdinaryShares		usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Gain Loss On Sale Of Project GainLossOnSaleOfProject		usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	ipax	Deferred Offering Cost Paid By Related Party DeferredOfferingCostPaidByRelatedParty		usd
CY2022	ipax	Capital Contribution For Excess Fair Value Of Class B Shares Sold By The Sponsor To Anchor Investor CapitalContributionForExcessFairValueOfClassBSharesSoldByTheSponsorToAnchorInvestor		usd
CY2022	ipax	Deferred Underwriting Commissions Payable Charged To Additional Paid In Capital DeferredUnderwritingCommissionsPayableChargedToAdditionalPaidInCapital		usd
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense		usd
CY2022	ipax	Accrued Offering Costs AccruedOfferingCosts		usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001844452

Files In Submission

Name	View Source	Status
0001213900-23-024857-index-headers.html	Edgar Link	pending
0001213900-23-024857-index.html	Edgar Link	pending
0001213900-23-024857.txt	Edgar Link	pending
0001213900-23-024857-xbrl.zip	Edgar Link	pending
f10k2022ex21-1_intuitive.htm	Edgar Link	pending
f10k2022ex31-1_intuitive.htm	Edgar Link	pending
f10k2022ex31-2_intuitive.htm	Edgar Link	pending
f10k2022ex32-1_intuitive.htm	Edgar Link	pending
f10k2022ex32-2_intuitive.htm	Edgar Link	pending
f10k2022_intuitivemac.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ipax-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ipax-20221231_cal.xml	Edgar Link	unprocessable
ipax-20221231_def.xml	Edgar Link	unprocessable
ipax-20221231_lab.xml	Edgar Link	unprocessable
ipax-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_intuitivemac_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUNR
Intuitive Machines, Inc. Stock $lunr

2023 Q1 Form 10-K Financial Statement

#000121390023024857 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUNR Intuitive Machines, Inc. Stock $lunr

2023 Q1 Form 10-K Financial Statement

#000121390023024857 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUNR
Intuitive Machines, Inc. Stock $lunr